Zobrazeno 1 - 10
of 82
pro vyhledávání: '"So, Derek Y. F."'
Autor:
Mina Madan, J. Dawn Abbott, Ryan Lennon, Derek Y. F. So, Andrea M. MacDougall, Mary Ann McLaughlin, Vishakantha Murthy, Jacqueline Saw, Charanjit Rihal, Michael E. Farkouh, Naveen L. Pereira, Shaun G. Goodman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 12 (2022)
Background TAILOR‐PCI (Tailored Antiplatelet Initiation to Lessen Outcomes due to decreased Clopidogrel Response After Percutaneous Coronary Intervention) studied genotype‐guided selection of antiplatelet therapy after percutaneous coronary inter
Externí odkaz:
https://doaj.org/article/77975cb2cfd742aa851421e878a26824
Autor:
Mina Madan, Akshay Bagai, Christopher B. Overgaard, Jiming Fang, Maria Koh, Warren J. Cantor, Pallav Garg, Madhu K. Natarajan, Derek Y. F. So, Dennis T. Ko
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 13 (2019)
Background To manage overcrowding and bed shortages in Canadian hospitals, same‐day discharge (SDD) after percutaneous coronary intervention (PCI) has emerged as a solution to improve resource utilization. However, limited information exists regard
Externí odkaz:
https://doaj.org/article/7fef8aed99094726843cd9b8c9ddd1af
Autor:
Becky Skidmore, Jesse Elliott, Shannon E Kelly, Zemin Bai, Michel Boucher, Derek Y F So, George A Wells
Publikováno v:
BMJ Open, Vol 9, Iss 6 (2019)
IntroductionDual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting; however, there is ongoing debate about the optimal duration, especially in specific patient groups. In the propo
Externí odkaz:
https://doaj.org/article/c155e1dca88e4dffa98b5505c2f7607f
Autor:
Linnea M. Baudhuin, Laura J. Train, Shaun G. Goodman, Gary E. Lane, Ryan J. Lennon, Verghese Mathew, Vishakantha Murthy, Tamim M. Nazif, Derek Y. F. So, John P. Sweeney, Alan H. B. Wu, Charanjit S. Rihal, Michael E. Farkouh, Naveen L. Pereira
Publikováno v:
Pharmacogenomics J
The pharmacogenomics journal, vol 22, iss 5-6
The pharmacogenomics journal, vol 22, iss 5-6
Loss-of-function CYP2C19 variants are associated with increased cumulative ischemic outcomes warranting CYP2C19 genotyping prior to clopidogrel administration. TAILOR-PCI was an international, multicenter (40 sites), prospective, randomized trial com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3347d4cdb9635adeb2c8f3623bbbdbef
https://doi.org/10.1038/s41397-022-00278-4
https://doi.org/10.1038/s41397-022-00278-4
Publikováno v:
BMJ: British Medical Journal, 2011 May . 342(7807), 1096-1097.
Externí odkaz:
https://www.jstor.org/stable/23050996
Autor:
Benjamin Hibbert, Ronnen Maze, Ali Pourdjabbar, Trevor Simard, F Daniel Ramirez, Rohit Moudgil, Melissa Blondeau, Marino Labinaz, Alexander Dick, Christopher Glover, Michael Froeschl, Jean-François Marquis, Derek Y F So, Michel R Le May
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92078 (2014)
In patients undergoing primary percutaneous coronary intervention (PPCI) ticagrelor is superior to clopidogrel in reducing cardiovascular events. This study sought to evaluate the effect of clopidogrel pretreatment on the pharmacodynamics of ticagrel
Externí odkaz:
https://doaj.org/article/f13da19b10e74483ae267dfaf8069d04
Autor:
Baudhuin, Linnea M., Train, Laura J., Goodman, Shaun G., Lane, Gary E., Lennon, Ryan J., Mathew, Verghese, Murthy, Vishakantha, Nazif, Tamim M., So, Derek Y. F., Sweeney, John P., Wu, Alan H. B., Rihal, Charanjit S., Farkouh, Michael E., Pereira, Naveen L.
Publikováno v:
The Pharmacogenomics Journal; December 2022, Vol. 22 Issue: 5-6 p303-307, 5p
Autor:
Madan, Mina, Abbott, J. Dawn, Lennon, Ryan, So, Derek Y. F., MacDougall, Andrea M., McLaughlin, Mary Ann, Murthy, Vishakantha, Saw, Jacqueline, Rihal, Charanjit, Farkouh, Michael E., Pereira, Naveen L., Goodman, Shaun G., TAILOR‐PCI Investigators *
Publikováno v:
Journal of the American Heart Association; 6/21/2022, Vol. 11 Issue 12, p1-22, 22p
Autor:
Jean-Christophe, Bélanger, Fabio Luiz, Bandeira Ferreira, Mélanie, Welman, Rahma, Boulahya, Jean-François, Tanguay, Derek Y F, So, Marie, Lordkipanidzé
Publikováno v:
Journal of Clinical Medicine
The vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation level is a highly specific method to assess P2Y12 receptor inhibition. Traditionally, VASP phosphorylation is analyzed by flow cytometry, which is laborious and restricted to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf57120de1f4b0ee7e4b67687dd96155
https://pubmed.ncbi.nlm.nih.gov/31991630
https://pubmed.ncbi.nlm.nih.gov/31991630
Autor:
Clifford, Cole R, Boudreau, Rene, Visintini, Sarah, Orr, Nathan, Fu, Angel Y N, Malhotra, Nikita, Barry, Quinton, So, Derek Y F
Publikováno v:
European Heart Journal - Cardiovasular Pharmacotherapy; September 2022, Vol. 8 Issue: 5 p511-518, 8p